-transparent.png){kind=logo}
Interleukin-1 (IL-1) enhances the growth of human monocytic leukemia cell line JOSK-I cells, which were recently established in our laboratory and which were demonstrated to produce a high level of IL-1 constitutively, in liquid as well as semisolid culture systems. Concomitantly, IL-1 stimulated the prostaglandin E2 synthesis and nitroblue tetrazolium dye-reducing capacity of JOSK-I cells. This indicates that IL-1 may act as autocrine growth factor for monocytes, and also suggests the possibility that this autocrine stimulation may play an important role in the pathophysiology of monocytic leukemia in vivo.
Related Publications
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
February 1993,
Blood,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
July 1988,
European journal of immunology,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
April 1989,
Proceedings of the National Academy of Sciences of the United States of America,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
May 1994,
Journal of cellular physiology,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
November 1990,
Proceedings of the National Academy of Sciences of the United States of America,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
September 1993,
Cancer research,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
September 1983,
Cellular immunology,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
January 1994,
Journal of gastroenterology and hepatology,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
November 1997,
Gastroenterology,
Y Furukawa, and
M Ohta, and
Y Miura, and
M Saito
April 1986,
Gan to kagaku ryoho. Cancer & chemotherapy,
